Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM



Status:Recruiting
Conditions:High Cholesterol, Cardiology, Orthopedic
Therapuetic Areas:Cardiology / Vascular Diseases, Orthopedics / Podiatry
Healthy:No
Age Range:18 - 65
Updated:11/10/2018
Start Date:March 20, 2017
End Date:December 30, 2021
Contact:Milind Desai, MD
Email:DESAIM2@CCF.ORG
Phone:2164445250

Use our guide to learn which trials are right for you!

Functional Capacity and Quality of Life Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy

Investigators aim to assess changes in exercise capacity and quality of life after septal
myectomy in patient with hypertrophic cardiomyopathy.

The objective of this study is to examine change in quality of life and functional capacity
as respectively measured by, Quality of Life Questionnaires and six-minute walk test
distance, following septal myectomy in patients with obstructive hypertrophic cardiomyopathy,
as compared to prior to surgery.

Inclusion Criteria:

- Scheduled to undergo septal myectomy.

- Established diagnosis of obstructive HCM defined as:

LVH Thickness ≥15mm left ventricular outflow tract gradient ≥50mmHg

Exclusion Criteria:

- Prior septal myectomy or alcohol septal ablation

- Prior myocardial infarction

- Uncontrolled arrhythmias including ventricular tachycardia and atrial fibrillation

- Uncontrolled hypertension

- Angiographically documented coronary stenosis >50%, if available at time of screening

- Inability to provide informed consent

- Inability to walk without assistive devices

- Peripheral artery disease with claudication
We found this trial at
1
site
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Phone: 216-445-5250
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials